InvestorsHub Logo
Followers 10
Posts 4272
Boards Moderated 0
Alias Born 11/12/2012

Re: Ubertino post# 65666

Tuesday, 02/19/2013 4:53:43 PM

Tuesday, February 19, 2013 4:53:43 PM

Post# of 146240
The only other supplier of cash is stockholders. By tripling its share count a drug developer can raise the cash to do its own phase 3 trials. That makes every share worth 1/3 of what it was worth before. It usually is better for the existing shareholders to make a deal with big pharma. BTW, if NNVC succeeds it will become one of those big pharma companies itself. Are you going to still hate on big pharma then?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News